Skip to main content

Gene Therapy

  • Chapter
  • First Online:
Advances in Biotechnology
  • 2969 Accesses

Abstract

Genes are the blueprints for proteins and serve as building blocks for tissues. Genes are regulators of chemical reactions inside the living cells. Mutation in a gene causes a change in the expressed structure of protein leading to protein dysfunction. Genetic errors disrupt gene expression and result in diseases. Advancement in biotechnology has helped in understanding the genetic basis of inherited diseases. Gene therapy is an experimental technique that uses genes as medicine for correcting defective genes that are responsible for disease development. Gene therapy has the potential to eliminate a wide range of inherited and acquired human diseases. A number of clinical trials in gene therapy are being carried out throughout the world. Gene therapy approach involves the treatment of disease by introducing new genetic instructions into the tissues of patients to correct the defective or abnormal gene. In gene therapy, mostly somatic (nonsex) cells are targeted for treatment. Due to controversies associated with the involvement of germ cells, this therapy is not attempted. As somatic gene therapy is directed at the individual, it has no impact on future generations. Changes directed at somatic cells are not inherited. The problem of “gene delivery” i.e., the need to get replacement genes into the desired tissues is the most difficult part and needs intensive research. The majority of current gene therapy clinical trials involve the mechanisms of viruses as “vectors”. These viral vectors are capable of integrating at random sites in the host’s cells. To date, gene therapy is being used to treat several genetic disorders. A large number of clinical trials are underway to test gene therapy as a treatment of choice for many life-threatening diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aartsma-Rus A, van Ommen GJ (2007) Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications. RNA 13:1609–1624

    Article  PubMed  CAS  Google Scholar 

  • Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L, Scaramuzza S, Andolfi G, Mirolo M, Brigida I (2009) Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 360(5):447–458

    Article  PubMed  CAS  Google Scholar 

  • Buchschacher GL (2001) Introduction to retroviruses and retroviral vectors. Somat Cell Mol Genet 26:1–11

    Article  PubMed  Google Scholar 

  • Bushman FD (2007) Retroviral integration and human gene therapy. J Clin Invest 117(8):2083–2086

    Article  PubMed  CAS  Google Scholar 

  • Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, Gross F, Yvon E, Nusbaum P, Selz F, Hue C, Certain S, Casanova JL (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288(5466):669–672

    Article  PubMed  CAS  Google Scholar 

  • Conese M, Ascenzioni F, Boyd AC (2011) Gene and cell therapy for cystic fibrosis: from bench to bedside. J Cystic Fibr 10(2):S114–S128

    Article  CAS  Google Scholar 

  • Deanna C, Burmester JK (2006) Gene therapy for cancer treatment: past, present and future. Clin Med Res 4(3):218–227

    Article  Google Scholar 

  • Li SD, Huang L (2006) Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Ther 13:1313–1319

    Article  PubMed  CAS  Google Scholar 

  • Mandel RJ, Manfredsson FP, Foust KD, Rising A, Reimsnider S, Nash K, Burger C (2006) Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders. Mol Ther 13:463–483

    Article  PubMed  CAS  Google Scholar 

  • Miller DG, Rutledge EA, Russell DW (2002) Chromosomal effects of adeno-associated virus vector integration. Nat Genet 30:147–148

    Article  PubMed  CAS  Google Scholar 

  • Niidome T, Huang L (2002) Gene therapy progress and prospects: nonviral vectors. Gene Ther 9:1647–1652

    Article  PubMed  CAS  Google Scholar 

  • Pelletier R, Caron SO, Puymirat J (2006) RNA based gene therapy for dominantly inherited diseases. Curr Gene Ther 6:131–146

    Article  PubMed  CAS  Google Scholar 

  • Patterson S, Papagatsias T, Benlahrech A (2009) Use of adenovirus in vaccines for HIV. Handb Exp Pharmacol 275–293

    Google Scholar 

  • St George JA (2003) Gene therapy progress and prospects: adenoviral vectors. Gene Ther 10:1135–1141

    Article  PubMed  CAS  Google Scholar 

  • Suzuki S, Tadakuma T, Kunitomi M, Takayama E, Sato M, Asano T (2001) Liposome-mediated gene therapy using HSV-TK/Ganciclovir under the control of human PSA promoter in prostate cancer cells. Urol Int 67:216–223

    Article  PubMed  CAS  Google Scholar 

  • Weidhaas JB, Angelichio EL, Fenner S, Coffin JM (2000) Relationship between retroviral DNA integration and gene expression. J Virol 74(18):8382–8389

    Article  PubMed  CAS  Google Scholar 

  • Wolff JA, Budker V (2005) The mechanism of naked DNA uptake and expression. Adv Genet 54:3–20

    PubMed  CAS  Google Scholar 

  • Woods NB, Bottero V (2006) Gene therapy: therapeutic gene causing lymphoma. Nature 440(7088):1123

    Article  PubMed  CAS  Google Scholar 

  • Wu Z, Asokan A, Samulski RJ (2006) Adeno-associated virus serotypes: Vector toolkit for human gene therapy. Mol Ther 14:316–327

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Rohini .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer India

About this chapter

Cite this chapter

Rohini, K. (2014). Gene Therapy. In: Ravi, I., Baunthiyal, M., Saxena, J. (eds) Advances in Biotechnology. Springer, New Delhi. https://doi.org/10.1007/978-81-322-1554-7_4

Download citation

Publish with us

Policies and ethics